World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
104
Citations
38794
World Ranking
617
National Ranking
361

Medicine

D-Index
105
Citations
39719
World Ranking
6786
National Ranking
3582

David M. Margolis publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where David M. Margolis sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 403 publications — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

David M. Margolis D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where David M. Margolis sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 104 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

David M. Margolis is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research focuses primarily on medicine, with a significant emphasis on immunology and microbiology.

Their work extensively covers subfields such as infectious diseases, virology, immunology, molecular biology, and epidemiology.

Key research topics include

  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • HIV/AIDS Research and Interventions
  • Immune Cell Function and Interaction
  • HIV-related health complications and treatments
  • SARS-CoV-2 and COVID-19 Research
  • Cytomegalovirus and herpesvirus research

Their frequent collaborators are

  • Nancie M. Archin
  • Joseph J. Eron
  • Edward P. Browne
  • Cynthia L. Gay
  • JoAnn Kuruc

David M. Margolis has contributed to numerous publications, with notable venues including

  • UNC Libraries
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Virology
  • The Journal of Infectious Diseases
  • Open Forum Infectious Diseases

Selected recent papers authored or co-authored by David M. Margolis include:

  • "SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract" (2020, Cell)
  • "SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo" (2020, Science)
  • "The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients" (2020, Science Immunology)
  • "Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women" (2021, New England Journal of Medicine)
  • "Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo" (2020, Nature)

Best Publications

  • SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.

    Yixuan J. Hou;Kenichi Okuda;Caitlin E. Edwards;David R. Martinez

  • Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

    N. M. Archin;A. L. Liberty;A. D. Kashuba;S. K. Choudhary

  • The challenge of finding a cure for HIV infection.

    Douglas D. Richman;David M. Margolis;Martin Delaney;Warner C. Greene

  • SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

    Yixuan J. Hou;Shiho Chiba;Peter Halfmann;Camille Ehre

  • The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients.

    Lakshmanane Premkumar;Bruno Segovia-Chumbez;Ramesh Jadi;David R. Martinez

  • Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease.

    Elizabeth A Worthey;Alan N Mayer;Alan N Mayer;Grant D Syverson;Daniel Helbling

  • Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

    Ginger Lehrman;Ian B Hogue;Sarah Palmer;Cheryl Jennings

  • Effect of NASA light-emitting diode irradiation on wound healing.

    Harry T. Whelan;Robert L. Smits;Ellen V. Buchman;Noel T. Whelan

  • Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

    Francois Raffi;Anita Rachlis;Hans-Jürgen Stellbrink;W David Hardy

  • Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy.

    Janis T. Eells;Margaret T.T. Wong-Riley;James VerHoeve;Michele Henry

  • Towards an HIV cure: a global scientific strategy

    Steven G Deeks;Brigitte Autran;Ben Berkhout;Monsef Benkirane

  • Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

    David A. Margolis;Juan Gonzalez-Garcia;Hans Jürgen Stellbrink;Joseph J. Eron

  • Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression

    Susan Swindells;Jaime-Federico Andrade-Villanueva;Gary J. Richmond;Giuliano Rizzardini

  • Clinical and experimental applications of NIR-LED photobiomodulation.

    Kristina D Desmet;David A Paz;Jesse J Corry;Janis T Eells

  • International AIDS Society global scientific strategy: towards an HIV cure 2016

    Steven G Deeks;Sharon R Lewin;Anna Laura Ross;Jintanat Ananworanich

  • An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients.

    Celsa A. Spina;Celsa A. Spina;Jenny Anderson;Nancie M. Archin;Alberto Bosque

  • Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report

    Mark C. Walters;Rainer Storb;Melinda Patience;Wendy Leisenring

  • Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

    Chloe Orkin;Keikawus Arasteh;Miguel Górgolas Hernández-Mora;Vadim Pokrovsky

  • Inhibition of HIV Fusion with Multivalent Gold Nanoparticles

    Mary Catherine Bowman;T. Eric Ballard;Christopher J. Ackerson;Daniel L. Feldheim

  • Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies

    Amanda M. Crooks;Rosalie Bateson;Anna B. Cope;Noelle P. Dahl

  • The Human Factors YY1 and LSF Repress the Human Immunodeficiency Virus Type 1 Long Terminal Repeat via Recruitment of Histone Deacetylase 1

    Jason J. Coull;Fabio Romerio;Jian Min Sun;Janet L. Volker

  • Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid

    Nancie M. Archin;Amy Espeseth;Daniel Parker;Manzoor Cheema

Frequent Co-Authors

Nancie M. Archin
Nancie M. Archin University of North Carolina at Chapel Hill
Joseph J. Eron
Joseph J. Eron University of North Carolina at Chapel Hill
Guido Ferrari
Guido Ferrari Duke University
Ronald J. Bosch
Ronald J. Bosch Harvard University
Guido Silvestri
Guido Silvestri Emory University
Barton F. Haynes
Barton F. Haynes Duke University
John W. Mellors
John W. Mellors University of Pittsburgh
Daria J. Hazuda
Daria J. Hazuda MSD (United States)
John M. Coffin
John M. Coffin Tufts University
Robert F. Siliciano
Robert F. Siliciano Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare fields through online programs can open diverse career pathways. Accelerated nursing programs offer a swift transition into the nursing profession. If you're searching for options, consider looking for accelerated nursing programs near me to find convenient, fast-track routes.

For those starting their nursing journey, finding the right Licensed Practical Nurse program is crucial. Understanding which LPN programs are easiest to get into can help aspiring nurses select schools that match their goals and academic preparation.

Advancing further, many students explore nurse practitioner degrees to expand their clinical expertise. Identifying the easiest online nurse practitioner programs can provide flexible learning options while balancing other commitments.

Specializing in mental health? Online Psychiatric Mental Health Nurse Practitioner programs stand out for clinical placement success. Researching the best PMHNP programs online is key for securing valuable hands-on experience.

Best Scientists Citing David M. Margolis

Trending Scientists

Recently Published Articles